Year: 2021

Los Angeles CA, Dec. 13, 2021 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), an award-winning, full service blockchain platform provider, is pleased to announce that it has been engaged by Indefinite Games to audit the NFT contracts for the upcoming public release of Robo Rampage, a blockchain-based play-to-earn game. A pioneer of the NFT space, CurrencyWorks has already established revolutionary platforms to serve the growing demand for digital token services and collectibles with its VUELE™ (film distribution) and Motoclub (digital automotive collectibles) partnerships. The Company recently announced the expansion of its services within the entertainment arena through MusicFX. This marks CurrencyWorks entry into the NFT play-to-earn market as it leverages both its...

OTC Markets Removes The Shell Risk Symbol On GMER From The OTCIQ System Kennett Square, PA, Dec. 13, 2021 (GLOBE NEWSWIRE) — Good Gaming, Inc. (OTCQB: GMER) (the “Company”) is pleased to announce the greatly anticipated mainnet launch of its first to market NFT game Microbuddies™ on Friday, December 17, 2021, at 7:00 PM EST. As previously reported, the Company announced plans last week to have all Nano Factory Token holders who have been involved in the Beta I and Beta II testing program vote on launch readiness based on their gameplay and user experience. With a majority vote in excess of 95%, the voters have spoken, and the game will be launching this Friday at 7:00 PM EST. The Company is preparing to permanently bridge over to the Polygon blockchain through the Polygon mainnet, which will allow for faster transactions...

Award recognizes extraordinary contributions to the growth of life sciences MIRAMAR, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, announced today Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, was named the 2021 Weaver H. Gaines Entrepreneur of the Year by BioFlorida. Presented annually at the BioFlorida Conference, the award recognizes an individual who has made extraordinary contributions to the growth of life sciences in the leadership of a company or institution. This marks the second time Dr. Wong has received the award; the first being in 2017. The award...

NTLA-2002 is the first single-dose genome editing therapeutic candidate designed to prevent angioedema attacks in patients with hereditary angioedema (HAE) to enter clinical study CAMBRIDGE, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, today announced that the first patient has been dosed with NTLA-2002, the company’s in vivo CRISPR/Cas9 genome editing candidate being developed as a single-dose therapy to prevent attacks in people living with hereditary angioedema (HAE). NTLA-2002 is a systemically administered therapy designed to inactivate the target gene kallikrein B1 (KLKB1) to reduce plasma kallikrein activity and thus prevent HAE attacks. “HAE...

Qilu Pharmaceutical, one of the leading pharmaceutical companies in China, becomes strategic partner to provide development, manufacturing and commercialization expertise for the mainland China, Hong Kong, Macau and Taiwan markets Arbutus to receive $40 million in an upfront payment, up to $245 million in development and commercialization milestone payments, double-digit tiered royalties and a $15 million equity investment WARMINSTER, Pa. and JINAN, China, Dec. 13, 2021 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company dedicated to developing a cure for people with chronic hepatitis B virus (HBV) infection, and Qilu Pharmaceutical, one of the leading pharmaceutical companies in China, today announced that the companies have entered into an exclusive licensing agreement and...

NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Dec. 13, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced the Company has entered into a new agreement with holders of its convertible notes that provides for a 90-day moratorium on conversion of those convertible notes and a restriction on sales of common shares owned by those noteholders (collectively the “New Lockup”). This New Lockup was entered into immediately after the expiry of a similar agreement on December 10, 2021 which was announced on September 24, 2021 (the “Old Lockup”).  “We are very pleased that we were able to come to a resolution on the restriction on Ordinary share sales into the market with our convertible debt holders such that there will be fixed...

The Special Meeting of Alcanna Shareholders is postponed to January 7, 2022 Only 56.29% of the Alcanna Shares eligible to vote have voted as of the original deadline to vote by proxy of December 10, 2021.The current voting results show a lack of sufficient support to reach the necessary 66⅔% threshold of votes cast to consummate the Arrangement. Alcanna will continue to engage with Alcanna Shareholders during the one-time extensionAlcanna Shareholders who have questions about the Arrangement or need assistance with voting their Alcanna Shares should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 or by e-mail at assistance@laurelhill.com Deadline to Vote by Proxy is 10:00 AM (Mountain Time) on January 5, 2022EDMONTON, Alberta, Dec. 13, 2021 (GLOBE NEWSWIRE) — Alcanna Inc. (“Alcanna” or the “Company”)...

CELEBRATION, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) — KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that it has been named the 2021 David J. Gury Company of the Year by BioFlorida. The award, presented during the 2021 BioFlorida Annual Conference, is in recognition of the U.S. Food and Drug Administration’s (FDA) approval of AZSTARYS® for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older, and other important milestones achieved by KemPharm over the past year. Corium, Inc. is leading all commercialization efforts for AZSTARYS in the U.S. The David J. Gury Company of the Year Award recognizes a Florida-based life sciences company that has demonstrated significant, quantifiable achievements...

Digital Ally has begun receiving pre-orders and expects product shipping to commence during the first quarter of 2022 Lenexa, KS, Dec. 13, 2021 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), which develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety, and security for venues and events, today announced the release of its most advanced body-worn camera to date, the FirstVu PRO. The full featured, one-piece body camera is designed specifically for law enforcement to increase safety and improve efficiencies for officers and administrators. “We are extremely excited to announce the FirstVu PRO,” said Stan Ross, CEO of Digital Ally, adding, “The PRO is the leading product in our new family of next generation...